Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorbald van Hall

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Investigative Ophthalmology & Visual Science|February 24, 2009
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patientsWillem Maat, Arno R van der Slik, Dirk H J Verhoeven, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2017
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironmentGülçin Gezgin, Mehmet Dogrusöz, T Huibertus van Essen, et al.
Molecular Cancer Research : MCR|August 11, 2018
Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal MelanomaMark J de Lange, Rogier J Nell, Rajshri N Lalai, et al.
Immunology|October 11, 2022
Thermal-exchange HLA-E multimers reveal specificity in HLA-E and NKG2A/CD94 complex interactionsPaula Ruibal, Ian Derksen, Marjolein van Wolfswinkel, et al.
International Journal of Cancer|October 30, 2021
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell divisionLinda Borst, Marjolein Sluijter, Gregor Sturm, et al.
Oncotarget|October 14, 2015
Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanomaMark J de Lange, Sake I van Pelt, Mieke Versluis, et al.
Journal for Immunotherapy of Cancer|July 19, 2022
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapyChristianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans, et al.
Plos One|October 21, 2016
Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating LeukocytesT Huibertus van Essen, Sake I van Pelt, Inge H G Bronkhorst, et al.
The Journal of Biological Chemistry|April 28, 2007
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cellsSelina Khan, Martijn S Bijker, Jimmy J Weterings, et al.
International Journal of Cancer|September 28, 2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelHeng Sheng Sow, Hreinn Benonisson, Cor Breukel, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Investigative Ophthalmology & Visual Science|February 24, 2009
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patientsWillem Maat, Arno R van der Slik, Dirk H J Verhoeven, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2017
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironmentGülçin Gezgin, Mehmet Dogrusöz, T Huibertus van Essen, et al.
Molecular Cancer Research : MCR|August 11, 2018
Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal MelanomaMark J de Lange, Rogier J Nell, Rajshri N Lalai, et al.
Immunology|October 11, 2022
Thermal-exchange HLA-E multimers reveal specificity in HLA-E and NKG2A/CD94 complex interactionsPaula Ruibal, Ian Derksen, Marjolein van Wolfswinkel, et al.
International Journal of Cancer|October 30, 2021
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell divisionLinda Borst, Marjolein Sluijter, Gregor Sturm, et al.
Oncotarget|October 14, 2015
Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanomaMark J de Lange, Sake I van Pelt, Mieke Versluis, et al.
Journal for Immunotherapy of Cancer|July 19, 2022
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapyChristianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans, et al.
Plos One|October 21, 2016
Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating LeukocytesT Huibertus van Essen, Sake I van Pelt, Inge H G Bronkhorst, et al.
The Journal of Biological Chemistry|April 28, 2007
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cellsSelina Khan, Martijn S Bijker, Jimmy J Weterings, et al.
International Journal of Cancer|September 28, 2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelHeng Sheng Sow, Hreinn Benonisson, Cor Breukel, et al.
Pageof 13